-
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
Hospital Resource Utilization and Estimated Costs Associated with Nipocalimab: Post-hoc Analysis of the Placebo-Controlled VIVACITY-MG3 Trial in Generalized Myasthenia Gravis
Mar 10, 2025, 14:00 PM -
Demonstrating Broader Economic Impact of Oncology Diagnostics and Therapeutics on Healthcare Resource Utilization Across All Relevant Specialties
Mar 10, 2025, 14:00 PM -
Addressing Neighborhood-Level Opioid Data Gaps: Development of an Interactive Dashboard for Prescription Trends and Buprenorphine Access in California
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database
Mar 10, 2025, 14:00 PM -
Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring
Mar 10, 2025, 14:00 PM -
Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database
Mar 10, 2025, 14:00 PM -
Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies
Mar 10, 2025, 14:00 PM -
Racial/Ethnic Disparities in Pneumococcal Vaccination Rates Among the Elderly: Trends and Associated Factors in the U.S., 2018-2023
Mar 10, 2025, 14:00 PM -
Uncovering the Cost of Red Blood Cell (RBC) and Platelet (PLT) Transfusions in Africa, Asia, Oceania, and the Americas and Exploring Related Implications in a Trial Example
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D
Mar 10, 2025, 14:00 PM -
A Comprehensive Review of Real-World Evidence (RWE) Use in Submissions to Canada's Drug Agency (CDA)
Mar 10, 2025, 14:00 PM -
Cost Per Responder Analysis of Patients With 3 Previous Lines and Lenalidomide Refractory Multiple Myeloma Who Received Cilta-Cel in the Brazilian Private Health System
Mar 10, 2025, 14:00 PM -
Analysis of the Quality of Life of Patients Undergoing Hip Replacement Surgery Using the SF-36 Questionnaire
Mar 10, 2025, 14:00 PM -
Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)
Mar 10, 2025, 14:00 PM -
Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates
Mar 10, 2025, 14:00 PM -
The Cost-Effectiveness of Eteplirsen vs. Standard of Care in Delaying the Progression of Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling.
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Clinical and Economic Impact of RBT-1 on Post-Operative Complications and Costs of Cardiac Surgery
Mar 10, 2025, 14:00 PM
